SC Labs acquired C4 Laboratories, based in Scottsdale, Arizona. SC Labs is now licensed and accredited in five states: California, Colorado, Michigan, Oregon and Arizona.
"We're thrilled to welcome the C4 team to the SC Labs family," stated Jeff Journey, CEO of SC Labs. "C4 has a demonstrated track record of scientific expertise and business acumen that fits perfectly within our values shared across locations. With this acquisition, we can continue to expand best-in-market cannabis testing services and the opportunity to service multi-state growers and manufacturers. It is truly an exciting time for growth, and we know that the C4 team will be an invaluable addition to our team, culture and operations."
In regulated cannabis markets, products for sale are required to undergo a series of tests by a state-approved lab to help ensure products are contaminant free and accurately labeled for consumers. However, despite regulations, many operators have recently faced rampant allegations of testing fraud across the country, which makes it more critical than ever for consumers to be confident that their products have been tested by science-first labs. In addition to the C4 acquisition, SC Labs also recently announced a new safety and ethics program in collaboration with ACT Laboratories, Trustintesting.org, to further ensure that what is on the label is in the package.
"As a part of SC Labs, we have an exciting opportunity to become the largest cannabis testing platform in the US," stated Ryan Treacy, CEO and founder of C4 Labs. "Our combined leverage of top scientists with specialized cannabis testing knowledge and a leadership team of industry experts will allow us to do everything from harmonizing R&D efforts to improving the data experience to pushing for positive regulatory change. The potential of what we can do together is limitless."
All C4 Lab employees will join the SC Labs team.
Related News
EXCLUSIVE: Kiva To Give Away Over 70K Edibles To California MMJ Patients Via New Donation Program
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
The Benzinga Cannabis Capital Conference is coming to Florida
The Benzinga Cannabis Capital Conference is returning to Florida, in a new venue in Hollywood, on April 16 and 17, 2024. The two-day event at The Diplomat Beach Resort will be a chance for entrepreneurs, both large and small, to network, learn and grow. Renowned for its trendsetting abilities and influence on the future of cannabis, mark your calendars – this conference is the go-to event of the year for the cannabis world.
Get your tickets now on bzcannabis.com – Prices will increase very soon!